Christopher C Porter Selected Research

Biomarkers (Surrogate Marker)

1/2017	A Genome-Wide Loss-of-Function Screen Identifies SLC26A2 as a Novel Mediator of TRAIL Resistance.
12/2013	Inhibition of Wee1 sensitizes cancer cells to antimetabolite chemotherapeutics in vitro and in vivo, independent of p53 functionality.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Christopher C Porter Research Topics

Disease

23	Neoplasms (Cancer) 03/2024 - 02/2003
16	Leukemia 10/2023 - 12/2013
5	Hematologic Neoplasms (Hematological Malignancy) 10/2023 - 10/2019
5	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 12/2013
5	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022 - 01/2004
2	Brain Neoplasms (Brain Tumor) 01/2023 - 01/2022
2	Autoimmune Diseases (Autoimmune Disease) 01/2023 - 01/2021
2	Thrombocytopenia (Thrombopenia) 10/2019 - 05/2015
2	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 10/2017 - 09/2015
2	Lung Neoplasms (Lung Cancer) 12/2013 - 08/2012
2	Human Influenza (Influenza) 01/2004 - 02/2003
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 03/2024
1	Genetic Predisposition to Disease (Genetic Predisposition) 10/2023
1	Graft vs Host Disease (Graft-Versus-Host Disease) 10/2023
1	Medulloblastoma 01/2023
1	Inflammation (Inflammations) 08/2022
1	Obesity 01/2022
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 01/2022
1	2-Hydroxyglutaricaciduria 01/2022
1	Cardiomyopathies (Cardiomyopathy) 01/2022
1	Arthritis (Polyarthritis) 01/2021
1	Hepatitis 01/2021
1	Multiple Sclerosis 01/2021
1	Down Syndrome (Down's Syndrome) 11/2019
1	Hypersensitivity (Allergy) 11/2019
1	Lesch-Nyhan Syndrome (Choreoathetosis Self Mutilation Hyperuricemia Syndrome) 01/2019
1	Second Primary Neoplasms (Neoplasms, Second) 01/2018
1	Osteopetrosis 01/2017
1	Chronic Granulomatous Disease 01/2017
1	Disease Progression 03/2016
1	Triple Negative Breast Neoplasms 03/2016
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 09/2014
1	Breast Neoplasms (Breast Cancer) 05/2014
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2012
1	Adenocarcinoma 08/2012
1	Peripheral Nervous System Diseases (PNS Diseases) 02/2009
1	Charcot-Marie-Tooth Disease (Peroneal Muscular Atrophy) 02/2009
1	Carcinogenesis 12/2005
1	Infections 02/2003

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 01/2023 - 09/2008
5	CytokinesIBA 01/2023 - 01/2017
4	adavosertibIBA 01/2018 - 12/2013
4	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2018 - 12/2013
3	RNA (Ribonucleic Acid)IBA 10/2023 - 01/2022
3	Interleukin-12 (IL 12)IBA 01/2022 - 01/2019
2	LigandsIBA 01/2022 - 01/2017
2	AntigensIBA 01/2022 - 01/2004
2	Phosphotransferases (Kinase)IBA 01/2020 - 09/2014
2	InterferonsIBA 11/2019 - 01/2017
2	CalcineurinIBA 01/2019 - 09/2014
2	Biomarkers (Surrogate Marker)IBA 01/2017 - 12/2013
2	AntimetabolitesIBA 09/2015 - 12/2013
2	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2004 - 02/2003
1	Dihydrotachysterol (AT 10)IBA 03/2024
1	DDMSIBA 10/2023
1	Fatty Acids (Saturated Fatty Acids)IBA 10/2023
1	Cisplatin (Platino)FDA LinkGeneric 01/2023
1	PlatinumIBA 01/2023
1	Messenger RNA (mRNA)IBA 01/2023
1	Interleukin-18 (Interleukin 18)IBA 08/2022
1	Interleukin-13IBA 08/2022
1	Single-Chain AntibodiesIBA 01/2022
1	Thrombopoietin (c-mpl Ligand)IBA 01/2022
1	Interleukin-10 (Interleukin 10)IBA 01/2022
1	AnthracyclinesIBA 01/2022
1	alpha-hydroxyglutarateIBA 01/2022
1	Chimeric Antigen ReceptorsIBA 01/2021
1	ChemokinesIBA 01/2021
1	Interferon Type IIBA 11/2019
1	Adenosine Monophosphate (AMP)IBA 10/2019
1	Uric Acid (Urate)IBA 01/2019
1	Complement System Proteins (Complement)IBA 01/2018
1	olaparibIBA 10/2017
1	1,25-dihydroxyvitamin D3-3-bromoacetateIBA 03/2016
1	Antineoplastic Agents (Antineoplastics)IBA 03/2016
1	NucleotidesIBA 05/2015
1	Tyrosine Kinase InhibitorsIBA 09/2014
1	Dasatinib (BMS 354825)FDA Link 09/2014
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 09/2014
1	ErbB Receptors (EGF Receptor)IBA 08/2012
1	TankyrasesIBA 08/2012
1	nutlin 3IBA 07/2012
1	Vincristine (Oncovin)FDA LinkGeneric 02/2009
1	Antifungal AgentsIBA 02/2009
1	Voriconazole (Vfend)FDA LinkGeneric 02/2009
1	Folic Acid (Vitamin M)FDA LinkGeneric 12/2005
1	DNA (Deoxyribonucleic Acid)IBA 12/2005
1	Hemagglutinins (Hemagglutinin)IBA 01/2004

Therapy/Procedure

11	Therapeutics 10/2023 - 02/2013
5	Immunotherapy 03/2024 - 10/2020
5	Drug Therapy (Chemotherapy) 01/2023 - 12/2013
2	Hematopoietic Stem Cell Transplantation 10/2023 - 01/2019
1	Hematopoietic Stem Cell Mobilization 10/2023
1	Transplantation 10/2023
1	Radiotherapy 01/2023
1	Precision Medicine 01/2022
1	Rejuvenation 01/2021
1	Maintenance Chemotherapy 01/2004